Desacetylcinobufagin

Cat. No.: X22-05-ZQ212

Desacetylcinobufagin

Synonym: 4026-95-3; Desacetylcinobufagin; 5-[(1R,2S,4R,5R,6R,7R,10S,11S,14S,16R)-5,14-Dihydroxy-7,11-dimethyl-3-oxapentacyclo[8.8.0.02,4.02,7.011,16]octadecan-6-yl]pyran-2-one

  • MDL: MFCD01740865
  • CAS Number: 4026-95-3
  • Compound CID: 11877495
Product Size
10 mg; 20 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Desacetylcinobufagin has been shown to inhibit the growth of human tumor cells and induce apoptosis by inhibiting protein synthesis, which leads to cell death. Desacetylcinobufagin also inhibits the production of pro-inflammatory cytokines such as IL-1β and TNF-α by downregulating the expression of NF-κB, thereby reducing inflammation. Desacetylcinobufagin has been shown to be effective at preventing the development of tumors in both mice and rats. This compound has also been shown to have anti-inflammatory properties, which may be due to its ability to inhibit prostaglandin synthesis. This product can be used for content determination, identification, and pharmacological experiments, etc.
Molecular Weight
400.51
Molecular Formula
C24H32O5
Purity
≥98%, determined by HPLC.
Stability
The product is stable for two years when stored at the recommended temperature.
Form
Powder
Identity
Confirmed by MS and NMR.
Applications
Desacetylcinobufagin can be used for content determination, identification, and pharmacological experiments, etc.
Storage
Store at 4°C. Protect from light.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.